CLINICAL_TRIALS
trial_result
· 2012-09-27
Clinical Trial Update: A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial evaluating certolizumab pegol added to methotrexate for rheumatoid arthritis, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-27